GOLDBEK Holding, a fast growing and innovative German greeting card publishing company, has acquired 100% of ABC Kunst- und Glückwunschkartenverlag (its legal name is A. Boss & Co), a privately owned Swiss market leader in
Tags :Thomas Gysin
Samsung Ventures has made a strategic investment in Araris Biotech. The investment corporation, that was established to promote the development of new technologies, has invested in the company in an independent deal ahead of its
BGPartner has advised Araris Biotech in a CHF 24 million financing round, involving the two co-lead investors 4BIO Capital and Pureos Bioventures. Araris Biotech, a company pioneering antibody-drug conjugate (ADC) linker technology, intends to use the
BGPartner has advised a leading global provider of EAP (“employee assistance programme”) services on the successful acquisition of a European EAP provider and its subsidiaries. The transaction will allow the Swiss-based company to continue to
Memo Therapeutics, specialists in the field of antibody discovery and development, has closed an oversubscribed Series B financing round led by Swisscanto Invest at CHF37 million after securing an additional CHF23 million from a combination
BGPartner announces the promotion of Fabiola Anthamatten (pictured left) to managing associate and Thomas Gysin (pictured right) to senior associate. Both have been an integral part of the BGPartner team for several years.
The Swiss e-commerce agency and software house specializing in the design, development and operation of e-commerce solutions for SMEs, MySign has becomes part of the German Allgeier Group. The IT and software services company Allgeier
Numab Therapeutics, a clinical stage biopharmaceutical company developing next-generation multispecific antibody-based immunotherapies for cancer and inflammation, successfully closes CHF 100 million (approximately USD 110 million) in Series C financing Round. The financing was co-led by new investors
